# US 2026/0169010 A1 · Mass spectrometry of steroidal compounds in multiplex samples

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0169010 A1
- Document ID: US20260169010A1
- Status: Published application
- Kind: A1
- Application number: 19/462,819
- Filed: 2026-01-28
- Published: 2026-06-18
- Earliest claimed: 2009-12-11
- Assignees: Quest Diagnostics Investments Incorporated
- Applicants: Quest Diagnostics Investments Incorporated
- Inventors: Brett HOLMQUIST; Nigel J. CLARKE
- Web page: https://patentgrep.com/patent/US20260169010A1

## CPC

- G01N 33/82: involving vitamins {or their receptors}
- G01N 33/6848: {Methods of protein analysis involving mass spectrometry}
- G01N 33/6851: {Methods of protein analysis involving laser desorption ionisation mass spectrometry}
- H01J 49/0027: {Methods for using particle spectrometers}
- G01N 2458/15: Non-radioactive isotope labels, e.g. for detection by mass spectrometry
- G01N 2560/00: Chemical aspects of mass spectrometric analysis of biological material
- H01J 49/00: Particle spectrometers or separator tubes
- Y10T 436/212: Aromatic
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- H01J: ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS (spark-gaps H01T; electric arc lamps H05B31/00; particle accelerators H05H)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The invention relates to the quantitative measurement of steroidal compounds by mass spectrometry. In a particular aspect, the invention relates to methods for quantitative measurement of steroidal compounds from multiple samples by mass spectrometry.

## Claims

### Claim at position 1

1-16. (canceled)

### Claim 17

A kit for performing a quantitation assay for one or more steroid compounds comprising packaging material and one or more isotopically labeled internal standards,
wherein the one or more steroid compounds is a vitamin D metabolite.

### Claim 18 (depends on 17)

The kit of claim 17, wherein the isotopically labeled internal standard is deuterated.

### Claim 19 (depends on 18)

The kit of claim 18, wherein the isotopically labeled internal standard is selected from: 25OHD2-[6, 19, 19]-2H3, 25OHD2-[24, 24, 24, 25, 25, 25]-2H6, 25OHD3-[6, 19, 19]-2H3, 25OHD3-[24, 24, 24, 25, 25, 25]-2H6, 1α,25OHD2-[6, 19, 19]-2H3, 1α,250D112-[24, 24, 24, 25, 25, 25]-2H6, 1α,25OHD3-[6, 19, 19]-2H3, or 1α,25OHD3-[24, 24, 24, 25, 25, 25]-2H6.

### Claim 20 (depends on 17)

The kit of claim 17, wherein the amount of the isotopically labeled internal standard in in an amount sufficient for performing at least one vitamin D metabolite quantitation assay.

### Claim 21 (depends on 17)

The kit of claim 17, wherein the vitamin D metabolite is selected from: 25-hydroxyvitamin D2 or 25-hydroxyvitamin D3.
